S100A4 and cancer: Therefore, during the entire course of their lifespan, cancer cells with an acquired EMT program will remain tdTomato+/EGFP− even if they subsequently lose αSMA or Fsp1 gene expression, or when potentially reverting to an epithelial morphology upon speculated mesenchymal‐to‐epithelial transition (MET) to establish metastatic niches.